Search for: "ACTAVIS" Results 1 - 20 of 911
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2014, 6:45 pm by Richard M.
Actavis has the option to release the product before the speculated date. [read post]
29 Jul 2013, 8:45 am by JA Hodnicki
Actavis the Supreme Court held that settlement of a patent infringement suit in which the patentee of a... [read post]
10 May 2013, 2:16 pm by By WILLIAM ALDEN
Actavis, the maker of generic drugs, said that it was in early stage talks to acquire Warner Chilcott. [read post]
18 Feb 2010, 4:30 am by By DEALBOOK
Actavis has severed ties with Sweden's EQT in a bid for German drug maker Ratiopharm, Reuters reported. [read post]
22 May 2008, 3:05 am
The IPKat draws your attention to yesterday's Court of Appeal decision, delivered by Lord Justice Jacob, in Actavis v Merck. [read post]
17 Nov 2014, 6:34 am by By David Gelles
The $66 billion acquisition by Actavis would be the largest deal this year and would thwart the takeover effort of Valeant and William A. [read post]
31 Mar 2019, 8:24 am
Jane Lambert Supreme Court (Lady Hale, Lords Kerr, Sumption, Hodge and Briggs) Actavis Group PTC EHF and others v ICOS Corporation and another [2019] UKSC 15 (27 March 2019) In The Cialis Litigation - Actavis Group PTC EHF and Others v Icos Corp and Another 4 Oct 2016, I discussed Mr Justice Birss's judgment in Actavis and others v Eli Lilly and Co [2016] EWHC 1955 (Pat) (10 Aug 2016) [read post]
20 Jul 2018, 8:45 am by D Daniel Sokol
Carrier, Rutgers Law School describes The Rule of Reason in the Post-Actavis World. [read post]
25 Apr 2012, 1:39 pm by By MARK SCOTT
Watson Pharmaceuticals agreed on Wednesday to buy the Swiss drug maker Actavis Group for up to 4.5 billion euros ($5.9 billion), as the American company looked to expand its presence in overseas markets. [read post]
6 Mar 2015, 8:31 pm by Lawrence B. Ebert
Reuters reported on March 6:--Eli Lilly has lost a patent case in Germany over its blockbuster Alimta lung cancer drug to generic producer Actavis, hitting the U.S. drugmaker's future sales hopes for the medicine [read post]
27 Apr 2013, 4:17 pm by By MICHAEL J. DE LA MERCED
The two companies had been in talks for some time, and under the most recent terms of the proposed deal, Valeant would have paid more than $13 billion in stock to acquire Actavis, this person said. [read post]
20 May 2013, 5:03 am by By MICHAEL J. DE LA MERCED
The generic drug maker Actavis has agreed to buy the specialty pharmaceutical company Warner Chilcott in an all-stock deal after talks to sell itself to Valeant Pharmaceuticals fell apart last month. [read post]
24 Apr 2012, 7:33 am by By MARK SCOTT
Watson Pharmaceuticals is expected to offer 4.5 billion euros for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers. [read post]
16 Nov 2014, 11:37 am by By Michael J. de la Merced
Actavis would pay more than $210 a share for Allergan, people briefed on the matter said, possibly thwarting a monthslong hostile bid by Valeant Pharmaceuticals and William A. [read post]